Abstract
Recently the Lymphoma Study Group of Japan (LSGJ) proposed a new classification of non-Hodgkin's lymphomas (NHLs), diving NHLs into the follicular group consisting of three subsets and the diffuse group, 7. Each subset of the diffuse group is further divided into B or T cell types according to immunologic markers and/or morphologic prediction. In the review of 118 malignant lymphomas, the authors studied the 109 cases of NHLs, attempting to assess the clinicopathologic utility of this classification. Morphologic criteria, enzyme histochemistry, and immunoperoxidase technique were used to ensure the accuracy of the immunologic phenotyping. The results suggest that the LSGJ classification is easily reproducible and yields a more precise clinicopathologic correlation than traditional, morphologic classifications. Consistent with similar studies in Japan, this study demonstrated a low incidence of Hodgkin's disease (7.6% of all lymphomas) and follicular lymphomas (8.3% of all NHLs) and a high incidence of T cell lymphomas (34.9% of all NHLs). The incidence (45.9%) of extranodal presentation was high. These four features seem characteristic of lymphomas in Japan.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berard C. W., Cossman J., Jaffe E. S. Malignant lymphomas as tumours of the immune system. Br J Cancer. 1980 Jul;42(1):1–20. doi: 10.1038/bjc.1980.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bloomfield C. D., Gajl-Peczalska K. J., Frizzera G., Kersey J. H., Goldman A. I. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma. N Engl J Med. 1979 Sep 6;301(10):512–518. doi: 10.1056/NEJM197909063011002. [DOI] [PubMed] [Google Scholar]
- DeLellis R. A., Sternberger L. A., Mann R. B., Banks P. M., Nakane P. K. Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol. 1979 May;71(5):483–488. doi: 10.1093/ajcp/71.5.483. [DOI] [PubMed] [Google Scholar]
- Freeman C., Berg J. W., Cutler S. J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972 Jan;29(1):252–260. doi: 10.1002/1097-0142(197201)29:1<252::aid-cncr2820290138>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- Frizzera G., Gajl-Peczalska K. J., Bloomfield C. D., Kersey J. H. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases. Cancer. 1979 Apr;43(4):1216–1224. doi: 10.1002/1097-0142(197904)43:4<1216::aid-cncr2820430409>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
- Higuchi S., Suga M., Dannenberg A. M., Jr, Schofield B. H. Histochemical demonstration of enzyme activities in plastic and paraffin embedded tissue sections. Stain Technol. 1979 Jan;54(1):5–12. doi: 10.3109/10520297909110667. [DOI] [PubMed] [Google Scholar]
- Li C. Y., Harrison G., Jr Histochemical and immunohistochemical study of diffuse large-cell lymphomas. Am J Clin Pathol. 1978 Nov;70(5):721–732. doi: 10.1093/ajcp/70.5.721. [DOI] [PubMed] [Google Scholar]
- Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- Lukes R. J., Taylor C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed] [Google Scholar]
- Nathwani B. N. A critical analysis of the classifications of non-Hodgkin's lymphomas. Cancer. 1979 Aug;44(2):347–384. doi: 10.1002/1097-0142(197908)44:2<347::aid-cncr2820440202>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Pallesen G., Madsen M., Hastrup J. Large-cell T-lymphoma with hypersegmented nuclei. Scand J Haematol. 1981 Jan;26(1):72–79. doi: 10.1111/j.1600-0609.1981.tb01627.x. [DOI] [PubMed] [Google Scholar]
- Rosas-Uribe A., Rappaport H. Malignant lymphoma, histiocytic type with sclerosis (sclerosing reticulum cell sarcoma). Cancer. 1972 Apr;29(4):946–953. doi: 10.1002/1097-0142(197204)29:4<946::aid-cncr2820290441>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Rudders R. A., Ross M. E., DeLellis R. A. Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer. 1978 Aug;42(2):406–416. doi: 10.1002/1097-0142(197808)42:2<406::aid-cncr2820420205>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Suchi T., Tajima K., Nanba K., Wakasa H., Mikata A., Kikuchi M., Mori S., Watanabe S., Mohri N., Shamoto M. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type. Acta Pathol Jpn. 1979 Sep;29(5):755–776. doi: 10.1111/j.1440-1827.1979.tb00942.x. [DOI] [PubMed] [Google Scholar]
- Taylor C. R. An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease. Eur J Cancer. 1976 Jan;12(1):61–75. doi: 10.1016/0014-2964(76)90125-0. [DOI] [PubMed] [Google Scholar]
- Tokunaga M., Sato E. Non-Hodgkin's lymphomas in a southern prefecture in Japan: an analysis in 715 cases. Cancer. 1980 Sep 1;46(5):1231–1239. doi: 10.1002/1097-0142(19800901)46:5<1231::aid-cncr2820460525>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- Waldron J. A., Leech J. H., Glick A. D., Flexner J. M., Collins R. D. Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic, and clinical features in six patients. Cancer. 1977 Oct;40(4):1604–1617. doi: 10.1002/1097-0142(197710)40:4<1604::aid-cncr2820400433>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Yamanaka N., Ishii Y., Koshiba H., Mikuni C., Ogasawara M., Kikuchi K. A study of surface markers in non-Hodgkin's lymphoma by using anti-T and anti-B lymphocyte sera. Cancer. 1981 Jan 15;47(2):311–318. doi: 10.1002/1097-0142(19810115)47:2<311::aid-cncr2820470217>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]